featured
Efficacy and Safety of Toripalimab in Previously Treated Recurrent or Metastatic Nasopharyngeal Carcinoma
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Journal of Clinical Oncology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Efficacy, Safety, and Correlative Biomarkers of Toripalimab in Previously Treated Recurrent or Metastatic Nasopharyngeal Carcinoma: A Phase II Clinical Trial (POLARIS-02)
J. Clin. Oncol 2021 Jan 25;[EPub Ahead of Print], FH Wang, XL Wei, J Feng, Q Li, N Xu, XC Hu, W Liao, Y Jiang, XY Lin, QY Zhang, XL Yuan, HX Huang, Y Chen, GH Dai, JH Shi, L Shen, SJ Yang, YQ Shu, YP Liu, W Wang, H Wu, H Feng, S Yao, RH XuFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.